Clinical Trial Update: SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing SR34006 to a vitamin K antagonist for the treatment of pulmonary embolism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Drugs mentioned

• SR34006
• Warfarin (warfarin)

Snippet

Sponsor: Sanofi | Conditions: Pulmonary Embolism | Phase 3 | Status: COMPLETED